Literature DB >> 23734649

Recent advances in understanding inflammation and remodeling in the airways in chronic obstructive pulmonary disease.

Sukhwinder Singh Sohal1, Chris Ward, Wan Danial, Richard Wood-Baker, Eugene Haydn Walters.   

Abstract

The authors have reviewed the current literature on airway inflammation and remodeling in smoking-related chronic obstructive pulmonary disease (COPD). Detailed data on airway remodeling in COPD are especially sparse and how these changes lead to decline in lung function is not well understood. Small airway fibrosis and obliteration are likely to be the main contributors to physiological airway dysfunction and occur earlier than any subsequent development of emphysema. One potential mechanism contributing to small airway fibrosis/obliteration and change in extracellular matrix is epithelial-mesenchymal transition. When associated with angiogenesis (so-called epithelial-mesenchymal transition type 3) it may well also be the link with the development of cancer, which is closely associated with COPD, predominantly in large airways. The authors have focused on our recent publications in these areas. Further investigations teasing out these mechanisms will help improve our understanding of key airway disease processes in COPD, which may have major therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23734649     DOI: 10.1586/ers.13.26

Source DB:  PubMed          Journal:  Expert Rev Respir Med        ISSN: 1747-6348            Impact factor:   3.772


  40 in total

1.  Targeting epithelial-mesenchymal transition.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2015-07       Impact factor: 4.599

2.  Longitudinal airway remodeling in active and past smokers in a lung cancer screening population.

Authors:  Bertram J Jobst; Oliver Weinheimer; Torben Buschulte; Mila Trauth; Jan Tremper; Stefan Delorme; Nikolaus Becker; Erna Motsch; Marie-Luise Groß; Anke Trotter; Monika Eichinger; Hans-Ulrich Kauczor; Mark O Wielpütz
Journal:  Eur Radiol       Date:  2018-12-14       Impact factor: 5.315

3.  Ventilatory efficiency slope as a predictor of suitability for surgery in chronic obstructive pulmonary disease patients with lung cancer.

Authors:  Mathew Suji Eapen; Ravneet Grover; Kiran Ahuja; Andrew Williams; Sukhwinder Singh Sohal
Journal:  Ann Transl Med       Date:  2016-08

4.  Recognizing occupational effects of diacetyl: What can we learn from this history?

Authors:  Kathleen Kreiss
Journal:  Toxicology       Date:  2016-06-17       Impact factor: 4.221

5.  HIV infection model of chronic obstructive pulmonary disease in mice.

Authors:  Patrick Geraghty; Eran Hadas; Boe-Hyun Kim; Abdoulaye J Dabo; David J Volsky; Robert Foronjy
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-01-19       Impact factor: 5.464

6.  Involvement of urokinase in cigarette smoke extract-induced epithelial-mesenchymal transition in human small airway epithelial cells.

Authors:  Qin Wang; Yunshan Wang; Yi Zhang; Yuke Zhang; Wei Xiao
Journal:  Lab Invest       Date:  2015-02-23       Impact factor: 5.662

Review 7.  Airway and lung remodelling in chronic pulmonary obstructive disease: a role for muscarinic receptor antagonists?

Authors:  Michael Roth
Journal:  Drugs       Date:  2015-01       Impact factor: 9.546

8.  Ginsenoside Rg1 protects against cigarette smoke-induced airway remodeling by suppressing the TGF-β1/Smad3 signaling pathway.

Authors:  Sibin Guan; Ping Yu; Jianhong Cao; Xiaoling Xi; Qingliu Zhang; Chenying Zhu; Hao Hu; Xin Gong; Huimin Fan
Journal:  Am J Transl Res       Date:  2020-02-15       Impact factor: 4.060

9.  Oxidative stress-induced mitochondrial dysfunction drives inflammation and airway smooth muscle remodeling in patients with chronic obstructive pulmonary disease.

Authors:  Coen H Wiegman; Charalambos Michaeloudes; Gulammehdi Haji; Priyanka Narang; Colin J Clarke; Kirsty E Russell; Wuping Bao; Stelios Pavlidis; Peter J Barnes; Justin Kanerva; Anton Bittner; Navin Rao; Michael P Murphy; Paul A Kirkham; Kian Fan Chung; Ian M Adcock
Journal:  J Allergy Clin Immunol       Date:  2015-03-29       Impact factor: 10.793

10.  Gankyrin drives malignant transformation of chronic liver damage-mediated fibrosis via the Rac1/JNK pathway.

Authors:  X Zhao; J Fu; A Xu; L Yu; J Zhu; R Dai; B Su; T Luo; N Li; W Qin; B Wang; J Jiang; S Li; Y Chen; H Wang
Journal:  Cell Death Dis       Date:  2015-05-07       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.